# Loss of Ufsp1 does not cause major changes at the neuromuscular junction

**Authors:** Cristofer Calvo, Coalesco Smith, Taejeong Song, Fabian Montecino-Morales, Sakthivel Sadayappan, Douglas P. Millay, Minchul Kim

PMC · DOI: 10.1371/journal.pone.0328690 · PLOS One · 2025-08-01

## TL;DR

The study finds that Ufsp1, a protease involved in UFMylation, is not essential for normal development or muscle function in mice.

## Contribution

The paper demonstrates that Ufsp1 is not essential for neuromuscular junction integrity or mouse development.

## Key findings

- Ufsp1 mutants showed normal birth ratios and no major phenotypic abnormalities.
- Only mild structural changes were observed at neuromuscular junctions in Ufsp1 mutants.
- Ufsp1 is dispensable for normal development and muscle function in mice.

## Abstract

UFMylation is a Ubiquitin-like post-translational modification involved in myriad of cellular processes. Enzymes involved in this pathway, including ligases and UFM1-specific proteases, are essential for development and homeostasis. Our previous transcriptomic analyses identified an enrichment of Ufsp1 at the neuromuscular junction of skeletal muscle cells. Ufsp1, one of the two UFM1 proteases, had been considered a pseudogene due to truncation of its catalytic domain in several species, including humans. However, recent findings revealed that Ufsp1 is translated from a non-canonical start codon in humans, yielding a catalytically active enzyme. This discovery has revived interest in studying Ufsp1’s role in vivo. We generated two mutant mouse models, one with a point mutation abolishing catalytic activity and another with complete knockout of the gene. Unlike other UFMylation pathway enzymes, both Ufsp1 mutants were born in normal ratios and did not exhibit gross phenotypic abnormalities. Despite the enrichment of Ufsp1 at neuromuscular junctions, only mild structural alterations of this synapse were detected, which did not impact overall muscle function. Our findings indicate that Ufsp1 is dispensable for normal development and homeostasis in mice, but further exploration of its function is needed in pathological conditions.

## Linked entities

- **Genes:** UFSP1 (UFM1 specific peptidase 1) [NCBI Gene 402682], UFM1 (ubiquitin fold modifier 1) [NCBI Gene 51569]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Pax7 (paired box 7) [NCBI Gene 18509] {aka Pax-7}, Ufsp1 (UFM1-specific peptidase 1) [NCBI Gene 70240] {aka 2700038N03Rik, D5Ertd655e}, LOC105243590 (Ig heavy chain Mem5-like) [NCBI Gene 105243590] {aka IgH, Igg1}, UFSP1 (UFM1 specific peptidase 1) [NCBI Gene 402682] {aka UFSP}, Colq (collagen like tail subunit of asymmetric acetylcholinesterase) [NCBI Gene 382864] {aka A130034K24Rik}, Ufc1 (ubiquitin-fold modifier conjugating enzyme 1) [NCBI Gene 66155] {aka 1110021H02Rik, ESTM29}, Agrn (agrin) [NCBI Gene 11603] {aka Agrin, nmf380}, Ngf (nerve growth factor) [NCBI Gene 18049] {aka Ngfb, beta-NGF}, Musk (muscle, skeletal, receptor tyrosine kinase) [NCBI Gene 18198] {aka Mdk4, Mlk, Nsk1, Nsk2, Nsk3}, Syn1 (synapsin I) [NCBI Gene 20964] {aka Syn-1, Syn1-S}, Ufsp2 (UFM1-specific peptidase 2) [NCBI Gene 192169] {aka 1810047C23Rik}, LOC641025 (Ig heavy chain Mem5-like) [NCBI Gene 641025] {aka CRP55H, IGHV, IgVH, Igh, Igm}, Pphln1 (periphilin 1) [NCBI Gene 223828] {aka CR, HSPC206, HSPC232}, Ufl1 (UFM1 specific ligase 1) [NCBI Gene 67490] {aka 1810074P20Rik, Kiaa0776, Maxer, Rcad, mKIAA0776}, Ntf3 (neurotrophin 3) [NCBI Gene 18205] {aka HDNF, NGF-2, Nt3, Ntf-3}, Cat (catalase) [NCBI Gene 12359] {aka 2210418N07, Cas-1, Cas1, Cs-1}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], jt (joined toes) [NCBI Gene 16473] {aka syn}, UFM1 (ubiquitin fold modifier 1) [NCBI Gene 51569] {aka BM-002, C13orf20, HLD14}, Ufm1 (ubiquitin-fold modifier 1) [NCBI Gene 67890] {aka 1810045K17Rik, Gm10726}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Uba5 (ubiquitin-like modifier activating enzyme 5) [NCBI Gene 66663] {aka 5730525G14Rik, Ube1dc1}
- **Diseases:** muscle defects (MESH:D009135), structural abnormalities in skeletal muscle (MESH:C566527), viral infection (MESH:D014777), fibrosis (MESH:D005355), NMJ (MESH:D020511), muscle (MESH:D019042), neuromuscular (MESH:D009468), mitochondrial abnormalities (MESH:D028361)
- **Chemicals:** sucrose (MESH:D013395), oligonucleotide (MESH:D009841), acetylcholine (MESH:D000109), agarose (MESH:D012685), TBS (MESH:D013725), alcohol (MESH:D000438), SDS (MESH:D012967), sodium deoxycholate (MESH:D003840), isoflurane (MESH:D007530), CO2 (MESH:D002245), 2-methylbutane (MESH:C067038), Alexa Fluor 555 (MESH:C000608607), Triton X-100 (MESH:D017830), PBS (MESH:D007854), nitrogen (MESH:D009584), NP-40 (MESH:C010615), Trizol (MESH:C411644), haematoxylin (MESH:D006416), Laemmli buffer (MESH:C088816), MgCl2 (MESH:D015636), CKMix (-), NO (MESH:D009614), EDTA (MESH:D004492), NaCl (MESH:D012965), Cysteine (MESH:D003545), Tween-20 (MESH:D011136)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** C53A
- **Cell lines:** C2C12 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0188), CD-1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_5731), /6N — Mus musculus (Mouse), Transformed cell line (CVCL_D461)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12316231/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12316231/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC12316231/full.md

---
Source: https://tomesphere.com/paper/PMC12316231